![](https://monteverdelaw.com/wp-content/uploads/case-logo/acasti-pharma-inc.png)
Acasti Pharma, Inc. (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.
Acasti Pharma, Inc. (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.